Cite
Carpal tunnel syndrome in mucopolysaccharidosis type I Hurler-Scheie/Scheie and effect of enzyme replacement therapy
MLA
Matthew Pitt, et al. “Carpal Tunnel Syndrome in Mucopolysaccharidosis Type I Hurler-Scheie/Scheie and Effect of Enzyme Replacement Therapy.” Molecular Genetics and Metabolism, vol. 126, Feb. 2019, pp. S46–47. EBSCOhost, https://doi.org/10.1016/j.ymgme.2018.12.101.
APA
Matthew Pitt, Maureen Cleary, Deborah M. Eastwood, Benan Dala-Ali, Laura Guilder, & James Davison. (2019). Carpal tunnel syndrome in mucopolysaccharidosis type I Hurler-Scheie/Scheie and effect of enzyme replacement therapy. Molecular Genetics and Metabolism, 126, S46–S47. https://doi.org/10.1016/j.ymgme.2018.12.101
Chicago
Matthew Pitt, Maureen Cleary, Deborah M. Eastwood, Benan Dala-Ali, Laura Guilder, and James Davison. 2019. “Carpal Tunnel Syndrome in Mucopolysaccharidosis Type I Hurler-Scheie/Scheie and Effect of Enzyme Replacement Therapy.” Molecular Genetics and Metabolism 126 (February): S46–47. doi:10.1016/j.ymgme.2018.12.101.